Current Neuro-Oncology
Volume
25 Number 20
31 October 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 20, 31 October
Gordon JA, Pasli M, Cook CM, Connor
R, Boyer PJ, Ju AW, Lee KS, Knudson KE, Peach MS.
Novel
combination of GammaTile cesium-131 brachytherapy with
5-aminolevulinic acid fluorescence-guided resection in the
re-irradiation of pediatric recurrent high-grade glioma:
illustrative case.
J
Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23346∟.
doi: 10.3171/CASE23346∟.
PMID: 37870768∟.
Case report. ˍ
Habiboglu R, Kayali I, Saricanbaz I, Tezcan Y.
Comparative
Analysis of IDH Wild-Type Multifocal and Unifocal Glioblastomas:
Prognostic Factors and Survival Outcomes in Focus.
Turk
Neurosurg. 2023 Oct 16∟.
doi: 10.5137/1019-5149.JTN.45354-23.4∟.
PMID: 37846543∟.
Observational study. ˍ
*
Ong K, Hounjet C, Makarenko
S.
Intraoperative
and postoperative complications for repeat high-grade glioma
resections with concurrent chemotherapy: patient series.
J
Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23341∟.
doi: 10.3171/CASE23341∟.
PMID: 37870760∟.
Case report. ˍ
Owusu-Adjei B, Mietus CJ, Lim JC,
Lambert W, Daci R, Cachia D, Smith TW, Amenta PS.
Diffusely
invasive supratentorial rosette-forming glioneuronal tumor:
illustrative case.
J
Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23435∟.
doi: 10.3171/CASE23435∟.
PMID: 37870758∟.
Case report. ˍ
Tsukamoto Y, Natsumeda M, Takahashi H, Ueno A, Sakai K, Shida K,
Seto H, Saito T, Shibuma S, Nakayama Y, Tanaka Y, Nakano T, Ohta
A, Maruyama K, Okada M, Eda T, Seki Y, Yoneoka Y, Shimizu H,
Okamoto K, Kakita A, Oishi M.
Clinical,
imaging, and molecular features of radiation-induced glioblastomas
developing more than 20 years after radiation therapy for
intracranial germinomatous germ cell tumor: illustrative cases.
J
Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23361∟.
doi: 10.3171/CASE23361∟.
PMID: 37870755∟.
Case report. ˍ
Divé I, Weber KJ, Hartung
TI, Steidl E, Wagner M, Hattingen E, Franz K, Fokas E,
Ronellenfitsch MW, Herrlinger U, Harter PN, Steinbach
JP.
Gliomatosis
cerebri (GC) growth pattern: A single-center analysis of clinical,
histological, and molecular characteristics of GC and non-GC
glioblastoma.
Neurooncol
Adv. 2023 Oct 17;5(1):vdad131∟.
doi: 10.1093/noajnl/vdad131∟.
PMID: 38024242∟.
Observational study. ˍ
Sheng Z, Bu C, Mei J, Xu S, Zhang
Z, Guo G, Gao Y, Xing L, Chen Z, Hernesniemi J, Zemmar A, Bu
X.
Tracking
tumor evolution during the first-line treatment in brain glioma
via
serial
profiling of cell-free tumor DNA from tumor in
situ fluid.
Front
Oncol. 2023 Oct 17;13:1238607∟.
doi: 10.3389/fonc.2023.1238607∟.
PMID: 37920153∟.
Observational study. ˍ
Xiao Y, Cheng X, Jia L, Tian Y, He
J, He M, Chen L, Hao P, Li T, Chong W, Hai Y, You C, Peng L, Fang
F, Zhang Y.
Preoperative
hematocrit levels and postoperative mortality in patients
undergoing craniotomy for brain tumors.
Front
Oncol. 2023 Oct 17;13:1246220∟.
doi: 10.3389/fonc.2023.1246220∟.
PMID: 37916178∟.
Observational study. ˍ
Ling AL, Solomon IH, Landivar AM,
Nakashima H, Woods JK, Santos A, Masud N, Fell G, Mo X, Yilmaz AS,
Grant J, Zhang A, Bernstock JD, Torio E, Ito H, Liu J, Shono N,
Nowicki MO, Triggs D, Halloran P, Piranlioglu R, Soni H, Stopa B,
Bi WL, Peruzzi P, Chen E, Malinowski SW, Prabhu MC, Zeng Y,
Carlisle A, Rodig SJ, Wen PY, Lee EQ, Nayak L, Chukwueke U,
Gonzalez Castro LN, Dumont SD, Batchelor T, Kittelberger K,
Tikhonova E, Miheecheva N, Tabakov D, Shin N, Gorbacheva A,
Shumskiy A, Frenkel F, Aguilar-Cordova E, Aguilar LK, Krisky D,
Wechuck J, Manzanera A, Matheny C, Tak PP, Barone F, Kovarsky D,
Tirosh I, Suvà ML, Wucherpfennig KW, Ligon K, Reardon DA,
Antonio Chiocca E.
Clinical
trial links oncolytic immunoactivation to survival in
glioblastoma.
Nature.
2023 Oct 18∟.
doi: 10.1038/s41586-023-06623-2∟.
PMID: 37853118∟.
Interventional study. ˍ
Grassl N, Sahm K, Süße H, Poschke I, Bunse L, Bunse T,
Boschert T, Mildenberger I, Rupp AK, Ewinger MP, Lanz LM, Denk M,
Tabatabai G, Ronellenfitsch MW, Herrlinger U, Glas M, Krex D,
Vajkoczy P, Wick A, Harting I, Sahm F, von Deimling A, Bendszus M,
Wick W, Platten M.
INTERCEPT H3: a
multicenter phase I peptide vaccine trial for the treatment of
H3-mutated diffuse midline gliomas.
Neurol Res Pract.
2023 Oct 19;5(1):55∟.
doi: 10.1186/s42466-023-00282-4∟.
PMID: 37853454∟.
Interventional study
protocol. ˍ
Grudzień K,
Klimeczek-Chrapusta M, Kwiatkowski S, Milczarek O.
Predicting
the WHO Grading of Pediatric Brain Tumors Based on Their MRI
Appearance: A Retrospective Study.
Cureus.
2023 Oct 19;15(10):e47333∟.
doi: 10.7759/cureus.47333∟.
PMID: 38021610∟.
Observational study. ˍ
Kim N, Lee J, Nam DH, Lee JI, Seol
HJ, Kong DS, Choi JW, Chong K, Lee WJ, Chang JH, Kang SG, Moon JH,
Cho J, Lim DH, Yoon HI.
Impact
of boost sequence in concurrent chemo-radiotherapy on newly
diagnosed IDH-wildtype glioblastoma multiforme.
J
Neurooncol. 2023 Oct 20∟.
doi: 10.1007/s11060-023-04465-6∟.
PMID: 37861921∟.
Observational study˰ ˍ
Kulac I, Yenidogan I, Oflaz Sozmen
B, Baygul A, Cha S, Pekmezci M, Tihan T.
Pathological
perspectives in pilocytic astrocytomas: Extent of resection as the
sole critical factor for recurrence-free survival, and the
challenge of evaluating conclusions derived from limited
data.
Free
Neuropathol. 2023 Oct 20;4:4-17∟.
doi: 10.17879/freeneuropathology-2023-5116∟.
PMID: 37901684∟.
Observational study. ˍ
Stadler C, Gramatzki D, Le Rhun E, Hottinger AF, Hundsberger T,
Roelcke U, Läubli H, Hofer S, Seystahl K, Wirsching HG,
Weller M, Roth P.
Glioblastoma in the
oldest old: Clinical characteristics, therapy, and outcome in
patients aged 80 years and older.
Neurooncol
Pract. 2023 Oct 20;11(2):132-141. doi:
10.1093/nop/npad070. PMID:
38496908. Observational study. ˍ
Related article:
Roberto
K, Perry JR.
A
longer and/or better life for the oldest old with
glioblastoma.
Neurooncol
Pract.
2024 Jan 29;11(2):113-114. doi:
10.1093/nop/npae007. PMID:
38496918. Editorial˰ ˍ
Strowd R, Ellingson B, Raymond C,
Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL,
Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S.
Activity
of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients
with first recurrence of glioblastoma.
J
Neurooncol. 2023 Oct 21∟.
doi: 10.1007/s11060-023-04456-7∟.
PMID: 37864646∟.
Interventional study˰ ˍ
Wang L, Oill AT, Blanchard M, Wu M,
Hibbard J, Sepulveda S, Peter L, Kilpatrick J, Munoz M, Stiller T,
Shulkin N, Wagner J, Dolatabadi A, Nisis M, Shepphird J, Sanchez
G, Lingaraju C, Manchanda M, Natri H, Kouakanou L, Sun G,
Oliver-Cervantes C, Georges J, Aftabizadeh M, Forman S, Priceman
S, Ressler J, Arvanitis L, Cotter J, D'Apuzzo M, Tamrazi B, Badie
B, Davidson T, Banovich N, Brown C.
Expansion
of endogenous T cells in CSF of pediatric CNS tumor patients
undergoing locoregional delivery of IL13R⍺2-targeting CAR T
cells: an interim analysis.
Res
Sq [Preprint]. 2023 Oct 23:rs.3.rs-3454977∟.
doi: 10.21203/rs.3.rs-3454977/v1∟.
PMID: 37961215∟.
Interventional study. ˍ
Yang Y, Hu F, Wu S, Huang Z, Wei K,
Ma Y, Ou-Yang Q.
Blood-based
biomarkers: diagnostic value in brain tumors (focus on
gliomas).
Front
Neurol. 2023 Oct 23;14:1297835∟.
doi: 10.3389/fneur.2023.1297835∟.
PMID: 37936915∟.
Observational study. ˍ
*
Yang YC, Chen YS, Liao WC, Yin CH,
Lin YS, Chen MW, Chen JS.
Significant
perioperative parameters affecting postoperative complications
within 30 days following craniotomy for primary malignant brain
tumors.
Perioper
Med (Lond). 2023 Oct 23;12(1):54∟.
doi: 10.1186/s13741-023-00343-x∟.
PMID: 37872604∟.
Observational study. ˍ
Almeida C, Baptista Freitas M,
Costa A, Fernandes C, Barbosa M.
Extra-Neural
Metastases of Glioblastoma: A Case Series.
Cureus.
2023 Oct 24;15(10):e47556∟.
doi: 10.7759/cureus.47556∟.
PMID: 38021584∟.
Case report. ˍ
*
Kleinberg L, Ye X, Supko J, Stevens
GHJ, Shu HK, Mikkelsen T, Lieberman F, Lesser G, Lee E, Grossman
S.
A
Multi-Site Phase I Trial of Veliparib with Standard Radiation and
Temozolomide in Patients with Newly Diagnosed Glioblastoma
Multiforme (GBM).
Res
Sq [Preprint]. 2023 Oct 24:rs.3.rs-3466927∟.
doi: 10.21203/rs.3.rs-3466927/v1∟.
PMID: 37961385∟.
Interventional study. ˍ
Verma P, Singh BK, Sudhan MD, Singh
RK, Bagul SD, Chandak AR, Soni BK, Shelly D, Basu S.
68Ga-PSMA-11
PET/CT Imaging in Brain Gliomas and Its Correlation With
Clinicopathological Prognostic Parameters.
Clin
Nucl Med. 2023 Oct 24∟.
doi: 10.1097/RLU.0000000000004903∟.
PMID: 37883060∟.
Observational study˰ ˍ
White B, Filo J, Orrego-Gonzalez E,
Schwartz SN, Varma H, Uhlmann EJ, Vega RA.
Synchronous
contralateral low-grade oligodendroglioma and high-grade
IDH-mutant astrocytoma.
J
Neuropathol Exp Neurol. 2023 Oct 24:nlad088∟.
doi: 10.1093/jnen/nlad088∟.
PMID: 37875098∟.
Letter, Case report. ˍ
*
De Leon-Benedetti L, Narayanan S,
Lee VK, Panigrahy A, Boada F, Bhatia A.
The
use of sodium MRI in the diagnosis of an anaplastic astrocytoma
during immunotherapy: a case report.
Childs
Nerv Syst. 2023 Oct 25∟.
doi: 10.1007/s00381-023-06195-6∟.
PMID: 37878058∟.
Case report˰ ˍ
Grob ST, Miller KR, Sanford B,
Donson AM, Jones K, Griesinger AM, Amani V, Foreman NK, Liu A,
Handler M, Hankinson TC, Milgrom S, Levy JMM.
Genetic
predictors of neurocognitive outcomes in survivors of pediatric
brain tumors.
J
Neurooncol. 2023 Oct 25∟.
doi: 10.1007/s11060-023-04472-7∟.
PMID: 37878192∟.
Observational study. ˍ
Klawinski DM, Cottrell CE,
Schieffer KM, Indyk JA, Gandhi K, Mardis ER, Rodriguez DP,
Breneman JC, Osorio DS.
Fatal
brainstem injury following proton radiation in a patient with
medulloblastoma and a germline variant in RNF213.
Pediatr
Blood Cancer. 2023 Oct 25:e30739∟.
doi: 10.1002/pbc.30739∟.
PMID: 37877896∟.
Case report˰ ˍ
Nazem A, Lavezo J, Abdullaev Z,
Aldape K, Quezado M, Cimino PJ, Pratt DW, Jenkins RB, Ida
CM.
Diffuse
hemispheric glioma with H3-3B G34R mutation: Expanding the
spectrum of histone H3 genes in diffuse hemispheric glioma, H3
G34-mutant.
J
Neuropathol Exp Neurol. 2023 Oct 25:nlad089∟.
doi: 10.1093/jnen/nlad089∟.
PMID: 37878797∟.
Letter, Case report. ˍ
Schei S, Sagberg LM, Bø LE,
Reinertsen I, Solheim O.
Association
between patient-reported cognitive function and location of
glioblastoma.
Neurosurg
Rev. 2023 Oct 25;46(1):282∟.
doi: 10.1007/s10143-023-02177-z∟.
PMID: 37880432∟.
Observational study. ˍ
*
Stringer BW, De Silva MI, Greenberg
Z, Noreña Puerta A, Adams R, Milky B, Zabolocki M, van den
Hurk M, Ebert LM, Fairly Bishop C, Conn SJ, Kichenadasse G,
Michael MZ, Ormsby RJ, Poonoose S, Bardy C.
Human
cerebrospinal fluid affects chemoradiotherapy sensitivities in
tumor cells from patients with glioblastoma.
Sci
Adv. 2023 Oct 25;9(43):eadf1332∟.
doi: 10.1126/sciadv.adf1332∟.
PMID: 37878712∟.
Observational study. ˍ
Krugman J, Patel K, Cantor A,
Snuderl M, Cooper B, Zan E, Radmanesh A, Hidalgo ET, Nicolaides
T.
Pediatric
glioblastoma in the setting of constitutional mismatch-repair
deficiency treated with upfront lomustine and nivolumab.
Pediatr
Blood Cancer. 2023 Oct 26:e30757∟.
doi: 10.1002/pbc.30757∟.
PMID: 37881859∟.
Editorial˰ ˍ
Peyrl A, Chocholous M, Sabel M,
Lassaletta A, Sterba J, Leblond P, Nysom K, Torsvik I, Chi SN,
Perwein T, Jones N, Holm S, Nyman P, Mörse H, Öberg A,
Weiler-Wichtl L, Leiss U, Haberler C, Schmook MT, Mayr L,
Dieckmann K, Kool M, Gojo J, Azizi AA, André N, Kieran M,
Slavc I.
Sustained
Survival Benefit in Recurrent Medulloblastoma by a Metronomic
Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
JAMA
Oncol. 2023 Oct 26:e234437∟.
doi: 10.1001/jamaoncol.2023.4437∟.
PMID: 37883081∟.
Interventional study. ˍ
Di
Perri D, Hofstede D, Hartgerink D, Terhaag K, Houben R, Postma AA,
Hoeben A, Anten M, Ackermans L, Compter I, Eekers DBP.
Impact
of clinical target volume margin reduction in glioblastoma
patients treated with concurrent chemoradiation.
Neurooncol
Pract.
2023 Oct 27;11(3):249-254. doi:
10.1093/nop/npad071. PMID:
38737612. Observational study. ˍ
Ma S, Lee H, Jo WY, Byun YH, Shin
KW, Choi S, Oh H, Park CK, Park HP.
The
Warburg effect in patients with brain tumors: a comprehensive
analysis of clinical significance.
J
Neurooncol. 2023 Oct 27∟.
doi: 10.1007/s11060-023-04486-1∟.
PMID: 37889442∟.
Observational study˰ ˍ
Mohammad AH, Jatana S, Ruiz-Barerra
MA, Khalaf R, Al-Saadi T, Diaz RJ.
Metformin
use is associated with longer survival in glioblastoma patients
with MGMT gene silencing.
J
Neurooncol. 2023 Oct 27∟.
doi: 10.1007/s11060-023-04485-2∟.
PMID: 37889443∟.
Observational study˰ ˍ
*Omene E, Abdel-Rahman O, Batuyong E, Patel S, Coppens R, Easaw J,
Young K.
Switch to generic formulation
of temozolomide results in statistically significant increase in
grade 3 and 4 bone marrow toxicity in glioma patients in the
province of Alberta.
Neurooncol
Pract. 2023 Oct 27;11(2):171-177. doi:
10.1093/nop/npad065. PMID:
38496912. Observational study. ˍ
Pang NGT, Batara JMF, Luistro LTC,
Mojica CV, Domingo AJC.
Value
of Thallium-201 SPECT and SPECT/CT Brain Imaging in
Differentiating Malignant From Nonmalignant Lesions: A Comparative
Case-Series Study With Pathologic and/or Clinical
Correlation.
Brain
Tumor Res Treat. 2023 Oct 27;11(4):239-245∟.
doi: 10.14791/btrt.2023.0022∟.
PMID: 37953447∟.
Observational study. ˍ
Xu X, Zhang P, Zhuo Z, Duan Y, Qu
L, Cheng D, Sun T, Ding J, Xie C, Liu X, Haller S, Barkhof F, Ye
C, Zhang L, Liu Y.
Prediction
of H3K27M Alteration Status in Brainstem Glioma Using Multi-Shell
Diffusion MRI Metrics.
J
Magn Reson Imaging. 2023 Oct 27∟.
doi: 10.1002/jmri.29104∟.
PMID: 37889147∟.
Observational study˰ ˍ
Fukami S, Akimoto J, Nagai K, Saito Y, Kohno M.
Photodynamic
therapy using talaporfin sodium for non-totally resectable
malignant glioma.
Photodiagnosis
Photodyn Ther. 2023 Oct
28;45:103869. doi:
10.1016/j.pdpdt.2023.103869. PMID:
38787766. Observational study. ˍ
*Krolicki L, Kunikowska J, Cordier
D, Slavova N, Koziara H, Bruchertseifer F, Maecke HR, Morgenstern
A, Merlo A.
Long-Term
Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade
Gliomas (LGGs): A New Treatment Paradigm?
Int
J Mol Sci. 2023 Oct 28;24(21):15701∟.
doi: 10.3390/ijms242115701∟.
PMID: 37958683∟.
Observational study. ˍ
Pieczyńska A, Zasadzka E,
Pilarska A, Procyk D, Adamska K, Hojan K.
Rehabilitation
Exercises Supported by Monitor-Augmented Reality for Patients with
High-Grade Glioma Undergoing Radiotherapy: Results of a Randomized
Clinical Trial.
J
Clin Med. 2023 Oct 29;12(21):6838∟.
doi: 10.3390/jcm12216838∟.
PMID: 37959303∟.
Interventional study. ˍ
*
Alimohamadi M, Larijani A,
Pour-Rashidi A, Farzin M, Ebrahimi H, Rahmani M, Hendi K, Yarandi
KK, Aghajanian S, Shirani M.
Comparative
analysis of the prognostic significance of IDH,TERT, EGFR and MGMT
status in patients with adult non-H3-altered grade 4 gliomas: a
prospective cohort study.
World
Neurosurg. 2023 Oct 30:S1878-8750(23)01508-5∟.
doi: 10.1016/j.wneu.2023.10.102∟.
PMID: 37914076∟.
Observational study˰ ˍ
Christ SM, Youssef G, Tanguturi SK,
Cagney D, Shi D, McFaline-Figueroa JR, Chukwueke U, Lee EQ,
Hertler C, Andratschke N, Weller M, Reardon DA, Haas-Kogan D,
Guckenberger M, Wen PY, Rahman R.
Re-irradiation
of recurrent IDH-wildtype glioblastoma in the bevacizumab and
immunotherapy era: Target delineation, outcomes and patterns of
recurrence.
Clin
Transl Radiat Oncol. 2023 Oct 30;44:100697∟.
doi: 10.1016/j.ctro.2023.100697∟.
PMID: 38046107∟.
Observational study. ˍ
Young K, Cashion C, Ekberg S,
Hassall T, Bradford N.
Quality
of life and family functioning soon after paediatric brain tumour
diagnosis: A cross-sectional observational study.
Eur
J Oncol Nurs. 2023 Oct 31;67:102463∟.
doi: 10.1016/j.ejon.2023.102463∟.
PMID: 37951071∟.
Observational study. ˍ